Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias

Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias

Abstract Background Increasing evidence supports the use of plasma biomarkers of neurodegeneration and neuroinflammation to screen and diagnose patients with dementia. However, confirmatory studies are required to demonstrate their usefulness in the clinical setting. Methods We evaluated plasma and...

Full description

Bibliographic Details
Main Authors: Simone Baiardi, Corinne Quadalti, Angela Mammana, Sofia Dellavalle, Corrado Zenesini, Luisa Sambati, Roberta Pantieri, Barbara Polischi, Luciano Romano, Matteo Suffritti, Giuseppe Mario Bentivenga, Vanda Randi, Michelangelo Stanzani-Maserati, Sabina Capellari, Piero Parchi
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Alzheimer’s Research & Therapy
Subjects:
Frontotemporal dementia
FTLD
Alzheimer disease
Lewy bodies
Corticobasal syndrome
Progressive supranuclear palsy
Online Access:https://doi.org/10.1186/s13195-022-01093-6

Internet

https://doi.org/10.1186/s13195-022-01093-6

Similar Items